Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 3. Pharmacological venous thromboembolism prophylaxis.
作者信息
Thiengwittayaporn Satit, Budhiparama Nicolaas, Tanavalee Chotetawan, Tantavisut Saran, Sorial Rami M, Li Cao, Kim Kang-Il
机构信息
Department of Orthopaedic Surgery, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok, Thailand.
Nicolaas Institute of Constructive Orthopaedics Research and Education Foundation for Arthroplasty and Sports Medicine, Medistra Hospital, Jakarta, Indonesia.
出版信息
Knee Surg Relat Res. 2021 Aug 12;33(1):24. doi: 10.1186/s43019-021-00100-8.
Abstract
摘要
相似文献
1
Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 3. Pharmacological venous thromboembolism prophylaxis.
Knee Surg Relat Res. 2021 Aug 12;33(1):24. doi: 10.1186/s43019-021-00100-8.
2
Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis.
Knee Surg Relat Res. 2021 Jun 30;33(1):20. doi: 10.1186/s43019-021-00101-7.
3
Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 1. Diagnosis and risk factors.
Knee Surg Relat Res. 2021 Jun 19;33(1):18. doi: 10.1186/s43019-021-00099-y.
4
Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
J Arthroplasty. 2019 Apr;34(4):729-734. doi: 10.1016/j.arth.2018.12.015. Epub 2018 Dec 22.
5
Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
N Z Med J. 2020 Mar 13;133(1511):52-60.
6
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
Arch Intern Med. 2002 Jul 8;162(13):1465-71. doi: 10.1001/archinte.162.13.1465.
7
Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
J Bone Joint Surg Am. 2013 Jul 17;95(14):1256-64. doi: 10.2106/JBJS.L.00400.
8
Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
Thromb Res. 2014 May;133(5):719-24. doi: 10.1016/j.thromres.2014.01.039. Epub 2014 Feb 5.
9
Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med. 2000 Jun 6;132(11):853-61. doi: 10.7326/0003-4819-132-11-200006060-00002.
10
Non-Inferiority of Aspirin for Venous Thromboembolism Prophylaxis After Hip Arthroplasty in a Statewide Registry.
J Arthroplasty. 2021 Jun;36(6):2068-2075.e2. doi: 10.1016/j.arth.2021.01.025. Epub 2021 Jan 20.
引用本文的文献
1
Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study.
J Orthop Surg Res. 2025 Jun 16;20(1):589. doi: 10.1186/s13018-025-06004-7.
2
How to monitor and discriminate the causes of lower limb swelling during home-based rehabilitation after total knee arthroplasty? A delphi study.
Arthroplasty. 2025 Jan 7;7(1):3. doi: 10.1186/s42836-024-00285-9.
3
Comparison of total blood loss between limited tourniquet use and conventional tourniquet use in total knee arthroplasty: a randomized controlled trial.
BMC Musculoskelet Disord. 2024 Nov 15;25(1):918. doi: 10.1186/s12891-024-08058-w.
4
Incidence of Venous Thromboembolism after Primary Total Hip Arthroplasty with Mechanical Prophylaxis in Hong Kong Chinese.
Hip Pelvis. 2024 Jun 1;36(2):108-119. doi: 10.5371/hp.2024.36.2.108.
5
Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients.
BMC Surg. 2024 May 18;24(1):162. doi: 10.1186/s12893-024-02440-0.
6
Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials.
Front Pharmacol. 2024 Jan 8;14:1326224. doi: 10.3389/fphar.2023.1326224. eCollection 2023.
7
Incidence and Clinical Risk Factors of Post-Operative Complications following Primary Total Hip Arthroplasty: A 10-Year Population-Based Cohort Study.
J Clin Med. 2023 Dec 27;13(1):160. doi: 10.3390/jcm13010160.
8
Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery: A Survey of the Korean Hip Society.
Hip Pelvis. 2023 Sep;35(3):200-205. doi: 10.5371/hp.2023.35.3.200. Epub 2023 Sep 6.
9
Pharmacological thromboprophylaxis as a risk factor for early periprosthetic joint infection following primary total joint arthroplasty.
Sci Rep. 2022 Jun 22;12(1):10579. doi: 10.1038/s41598-022-14749-y.
10
Association between General Anesthesia and the Occurrence of Cerebrovascular Accidents in Hip Fracture Patients.
J Healthc Eng. 2021 Dec 18;2021:7271136. doi: 10.1155/2021/7271136. eCollection 2021.
本文引用的文献
1
A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study.
J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(1):2309499020905711. doi: 10.1177/2309499020905711.
2
Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
JAMA Intern Med. 2020 Mar 1;180(3):376-384. doi: 10.1001/jamainternmed.2019.6108.
3
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.
Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
4
Low-Dose Aspirin Is Adequate for Venous Thromboembolism Prevention Following Total Joint Arthroplasty: A Systematic Review.
J Arthroplasty. 2020 Mar;35(3):886-892. doi: 10.1016/j.arth.2019.09.043. Epub 2019 Oct 5.
5
The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89).
Br J Haematol. 2019 Sep;186(5):792-793. doi: 10.1111/bjh.16010. Epub 2019 Jun 5.
6
Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.
J Am Heart Assoc. 2019 May 21;8(10):e012184. doi: 10.1161/JAHA.119.012184.
7
Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group.
Acta Orthop. 2019 Aug;90(4):298-305. doi: 10.1080/17453674.2019.1611215. Epub 2019 May 7.
8
Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials.
J Orthop. 2019 Mar 21;16(4):294-302. doi: 10.1016/j.jor.2019.03.003. eCollection 2019 Jul-Aug.
9
Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
J Bone Joint Surg Am. 2019 Apr 3;101(7):589-599. doi: 10.2106/JBJS.18.00335.
10
Incidence of Symptomatic Venous Thromboembolism in Patients with Hemophilia Undergoing Hip and Knee Joint Replacement without Chemoprophylaxis: A Retrospective Study.
Orthop Surg. 2019 Apr;11(2):236-240. doi: 10.1111/os.12444. Epub 2019 Apr 1.
Zotero 插件